ACS - Acute Coronary SyndromeEuroHeart ITANCT07283809
European Unified Registries for Heart Care Evaluation and Randomised Trials Italy
An observational study of ACS - Acute Coronary Syndrome, run by Heart Care Foundation at 57 sites in Italy.
Trial summary
Major advances in cardiovascular medicine have been driven by innovations in basic research in biological and technical sciences. Despite the clear evidence regarding the treatments that have been demonstrated to be useful to improve patients' outcomes, their transferability to everyday clinical practice seems to be… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- ACS - Acute Coronary Syndrome
- What is being tested?
- Adherence to European Society of Cardiology (ESC) quality indicators
- How many people
- 5,000 participants
- Where
- 57 sitesItaly
- Study dates
- 15 Sep 2024to 30 Dec 2027
- How long will I take part?
- 12 Months
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: patients with ACS
Who may be able to join
- Patients ≥18 years of age.
- Males and females at birth.
- At least one of the following clinical conditions:
- Hospitalization for Acute Coronary Syndrome (ACS)
- Heart failure (HF, outpatients, and/or inpatients)
- Atrial fibrillation (A Fib, outpatients and/or inpatients)
- Signed informed consent for the study and for privacy.
Who cannot join
- patients who do not sign the consent to participate in the project and/or Privacy
Trial locations and contacts
57 sites in 1 country. Contact the study team or a site near you to ask about taking part.
57 sites in 1 country
Italy57 sites, 49 recruiting
- Recruiting
Ospedale Miulli - U.O.C. Cardiologia - Utic
Acquaviva delle Fonti, BA, 70021
Federica Troisi, MD, 00393494539015, federica.troisi@libero.it,f.troisi@miulli.it
- Recruiting
Ospedale Della Murgia - Fabio Perinei - S.C. Cardiologia-Utic
Altamura, BA, 70022
Angela Potenza, MD, 00393479934450, pot.angela@gmail.com,pot.angela@libero.it
- Recruiting
Ospedale Civile - U.O.C. Di Cardiologia
Arzignano, VI, 36071
Claudio Bilato, MD, 00393387105135, claudio.bilato@aulss8.veneto.it
- Recruiting
Ospedale San Paolo - Cardiologia-Utic
Bari, BA, 70123
Cosimo Campanella, MD, 00393298217131, cosimocamp@gmail.com
- Recruiting
Ospedale Di Venere - U.O.C. Di Cardiologia
Bari, BA, 70131
Francesco Cassano, MD, 00393351545454, fcassano1980@gmail.com
- Recruiting
Asst Spedali Civili - Cardiologia
Brescia, BS, 25123
Elio Gorga, 00393929448005, eliogorga@yahoo.it
- Recruiting
Ospedale A. Cardarelli - U.O. Cardiologia E Utic
Campobasso, CB, 86100
Angela Rita Colavita, MD, 00393392524959, angelarita.colavita@email.it,angelarita.colavita@asrem.org
- Recruiting
Azienda Ospedaliera S. Anna E S. Sebastiano - U.O. Cardiologia D'Emergenza Con Utic
Caserta, CE, 81100
Paolo Calabrò, MD, 00393284346963, paolo.calabro@unicampania.it
- Not yet recruiting
Ospedale Civile Ferrari - U.O.C. Cardiologia-Utic
Castrovillari, CS, 87012
Andrea Madeo, MD, 00393468603653, andreamadeo83@gmail.com
- Recruiting
Azienda Ospedaliera Cannizzaro - Uoc Cardiologia
Catania, CATANIA, 95126
Francesco Amico, MD, 00393389050175, famico64@gmail.com
- Not yet recruiting
P.O. "Pugliese" - A.O.U. "Renato Dulbecco" - Utic-Emodinamica E Cardiologia Interventistica
Catanzaro, CZ, 88100
Vincenzo Antonio Ciconte, MD, 00393939988521, enzocico2003@yahoo.it
- Recruiting
Ospedale Annunziata - Uoc Cardiologia
Cosenza, CS, 87100
Antonio Curcio, MD, 00393473304858, curcio@unicz.it,antonio.curcio.cardio@unical.it,antonio.curcio@aocs.it
- Active, not recruiting
Ospedale Di Cremona - Uo Di Cardiologia
Cremona, CR, 26100
- Recruiting
Ospedale San Giuseppe - Cardiologia
Empoli, FI, 50053
Francesco Calabrò, MD, 00393496462213, francecala@virgilio.it,francesco.calabro@uslcentro.toscana.it
- Recruiting
Ospedale Civile - U.O.C. Cardiologia - Utic
Fidenza, PR, 43036
Giovanni Tortorella, MD, 00393396604888, gtortorella@ausl.pr.it
- Active, not recruiting
Aou Careggi - Interventistica Cardiologica Strutturale
Florence, FI, 50134
- Recruiting
Policlinico Riuniti - S.C. Di Cardiologia Universitaria-Utic
Foggia, FG, 71100
Natale Daniele Brunetti, MD, 00393287660350, 00393389112358, natale.brunetti@unifg.it,natalebrunetti@gmail.com
- Recruiting
Irccs Ospedale Policlinico San Martino - Unita' Operativa Cardiologia
Genova, GE, 16132
Roberta Della Bona, MD, 00393479303133, roberta.dellabona@gmail.com
- Not yet recruiting
Ospedale Civile - S.C. Cardiologia
Ivrea, TO, 10015
Enrica Lonni, MD, 00393403669264, enrica.lonni@libero.it,lonni.enrica@gmail.com,elonni@aslto4.piemonte.it
- Recruiting
Casa Di Cura San Michele - Uo Cardiologia
Maddaloni, CE, 81024
Marco Pepe, MD, 00393402275139, marcpep@hotmail.it
- Recruiting
Ospedale Civile Fornaroli - U.O. Cardiologia
Magenta, MILANO, 20013
Alessandra Russo, MD, 00393468021501, alina2007russo@libero.it,alessandra.russo@asst-ovestmi.it
- Recruiting
Irccs Centro Neurolesi Bonino Pulejo - P.O. Piemonte - Cardiologia E Utic
Messina, MESSINA, 98124
Stefania Trifilo', MD, 00393404749270, stefaniatrifilo@gmail.com
- Recruiting
Policlinico G. Martino U.O.C - Cardiologia Con Utic
Messina, MESSINA, 98124
Patrizia Grimaldi, MD, 00393337168901, patgrima@alice.it,patrizia.grimaldi@polime.it
- Not yet recruiting
Irccs Ospedale San Raffaele - Area Unica Di Terapia Intensiva Cardiologica E Cch
Milan, MILANO, 20132
Vittorio Pazzanese, MD, 00393332272023, vittorio.pazzanese@hotmail.it,pazzanese.vittorio@hsr.it
- Active, not recruiting
Ospedale L. Sacco - Sc Cardiologia
Milan, MILANO, 20157
- Active, not recruiting
Asst Ospedale Metropolitano Niguarda - Cardiologia 1 - Emodinamica
Milan, Mlano, 20162
- Active, not recruiting
A.O.U. Cagliari Policlinico Monserrato - Sc Cardiologia Utic Emodinamica
Monserrato, CAGLIARI, 09124
- Recruiting
Ospedale Valdarno S. Maria Della Gruccia - U.O. Malattie Cardiovascolari
Montevarchi, AREZZO, 52027
Giovanni Falsini, MD, 00393486000920, giofalsini@gmail.com,giovanni.falsini@uslsudest.toscana.it
- Recruiting
Aou Federico Ii - Uoc Cardiologia Emodinamica Ed Utic
Naples, NAPOLI, 80131
Giovanni Esposito, MD, 00393386000855, espogiov@unina.it
- Recruiting
Irccs Ospedale Sacro Cuore Don Calabria - U.O. Di Cardiologia
Negrar, VR, 37024
GIULIO MOLON, MD, 00393358373237, giulio.molon@sacrocuore.it,elettrofisiologo@gmail.com
- Recruiting
Aou Maggiore Della Carita' - Ssvd Utic
Novara, 28100
Giuseppe Rocco Salvatore Patti, MD, 00393394296745, giuseppe.patti@uniupo.it
- Active, not recruiting
Azienda Ospedale-Universita Padova - Uosd Terapia Intensiva Cardiologica
Padova, PD, 35128
- Active, not recruiting
Aou Policlinico P. Giaccone - U.O.C. Cardiologia
Palermo, PALERMO, 90127
- Recruiting
Aor Villa Sofia-Cervello Po Villa Sofia - Uoc Cardiologia E Utic E Emodinamica -Villa Sofia
Palermo, PALERMO, 90146
Carlo Cicerone, MD, 00393398482237, carlo.cicerone@gmail.com,c.cicerone@villasofia.it
- Not yet recruiting
Azienda Ospedaliera Di Perugia - S.C. Cardiologia
Perugia, PG, 06129
Maurizio Del Pinto, MD, 00393356654474, maudp134@gmail.com
- Recruiting
Presidio Ospedaliero San Salvatore - Cardiologia E Utic
Pesaro, PU, 61121
Francesca Terzi, MD, 00393336181531, francesca.terzi@sanita.marche.it,francesca.terzi3@gmail.com
- Recruiting
Ospedale Civile Dello Spirito Santo - Cardiologia Con Utic
Pescara, PE, 65124
Massimo Di Marco, MD, 00393472505580, dimarcom@hotmail.com,massimo.dimarco@asl.pe.it
- Recruiting
Ospedale Giovanni Paolo Ii - U.O.C. Cardiologia-Utic
Ragusa, RG, 97100
Antonino Nicosia, MD, 00393398198339, antonino.nicosia@asp.rg.it
- Recruiting
Po Santa Maria Nuova - Ausl Re Irccs - Soc Cardiologia Ospedaliera
Reggio Emilia, RE, 42100
Alessandro Navazio, MD, 00393474535061, alessandro.navazio@ausl.re.it,a.navazio@iol.it
- Recruiting
P.O. San Camillo de Lellis - U.O.C. Cardiologia
Rieti, RIETI, 02100
Amir Kol, MD, 00393398057567, 00393398761877, a.kol@asl.rieti.it
- Not yet recruiting
Campus Biomedico - Cardiologia
Roma, RM, 00128
Rosetta Melfi, MD, 00393347235885, r.melfi@policlinicocampus.it
- Not yet recruiting
P.O. San Filippo Neri - Asl Roma 1 - Cardiologia Intensiva Ed Interventistica
Roma, RM, 00135
Veronica Melita, MD, 00393334559422, veronica.melita@gmail.com,veronica.melita@aslroma1.it
- Not yet recruiting
Ospedale Sandro Pertini - Uoc Cardiologia - Utic
Roma, RM, 00157
Paolo Trambaiolo, MD, 00393474473845, paolo.trambaiolo@gmail.com
- Not yet recruiting
Policlinico Casilino - U.O.C. Cardiologia
Roma, RM, 00169
Leonardo Calò, MD, 00393388589677, leonardo.calo@icloud.com,leonardocalo.doc@gmail.com
- Recruiting
Ospedale Madre Giuseppina Vannini - U.O.C. Cardiologia
Roma, RM, 00177
Emanuela Belmonte, MD, 00393398959555, ebelmonte.1@gmail.com
- Recruiting
Ospedale Santa Maria Del Carmine - U.O. Cardiologia Ad Indirizzo Elettrofisiologia
Rovereto, TRENTO, 38068
Maurizio Del Greco, MD, 00393356385963, maurizio.delgreco@apss.tn.it
- Recruiting
Ospedale Santa Maria Della Misericordia - U.O.C. Cardiologia
Rovigo, RO, 45100
Claudio Picariello, MD, 00393288622957, claudio.picariello@aulss5.veneto.it
- Not yet recruiting
Presidio Ospedaliero Di Saronno - U.O.C. Di Cardiologia
Saronno, VARESE, 21047
Daniele Nassiacos, MD, 00393384510961, nassidan@tin.it,daniele.nassiacos@asst-valleolona.it
- Recruiting
P.O. Levante - Ospedale San Paolo - S.C. Cardiologia Levante
Savona, SV, 17100
Alberto Somaschini, MD, 00393402387386, alberto.somaschini08@gmail.com
- Not yet recruiting
Aou Senese Ospedale S. Maria Alle Scotte - Cardiologia
Siena, SI, 53100
Serafina Valente, MD, 00393356508192, seravalente@gmail.com,serafina.valente@ao-siena.toscana.it
- Recruiting
Aou Citta' Della Salute E Della Scienza - S.C. Cardiologia U
Torino, TO, 10126
Pier Paolo Bocchino, MD, 00393488670565, pierpaolo1991@gmail.com
- Recruiting
Ospedale Santa Chiara - Divisione Di Cardiologia
Trento, TRENTO, 38122
Roberto Bonmassari, MD, 00393457950992, 00393666132146, roberto.bonmassari@apss.tn.it
- Recruiting
Ospedale Ca' Foncello - U.O.C. Cardiologia
Treviso, TV, 31100
Carlo Cernetti, MD, 00393472623082, carlocernetti@gmail.com,carlocernetti@live.com,carlocernetti@yahoo.it,carlo.cernetti@aulss2.veneto.it
- Recruiting
Asugi - Ospedale Di Cattinara - S.C. Cardiologia
Trieste, TS, 34149
Gianfranco Sinagra, MD, 00393333556032,00393207987915, gianfranco.sinagra@asugi.sanita.fvg.it
- Recruiting
Pou "Santa Maria Della Misericordia" - S.O.C. Cardiologia
Udine, UD, 33100
Massimo Imazio, MD, 00393296524271, massimo.imazio@uniud.it
- Recruiting
Ospedale San Luca - U.O. Utic - Cardiologia
Vallo della Lucania, SA, 84078
Antonio Aloia, MD, 00393333889863, tonialoia62@gmail.com
- Active, not recruiting
Aoui Di Verona - U.O. Cardiologia
Verona, VR, 37126
About this study
Official title: European Unified Registries for Heart Care Evaluation and Randomised Trials
Major advances in cardiovascular medicine have been driven by innovations in basic research in biological and technical sciences. Despite the clear evidence regarding the treatments that have been demonstrated to be useful to improve patients' outcomes, their transferability to everyday clinical practice seems to be at least suboptimal. The European Society of Cardiology (ESC), therefore, planned to support a program, denominated EuroHeart, for continuous data collection of standardized and/or harmonized variables in common cardiovascular diseases, such as ACS, HF and A Fib. EuroHeart is an observational, prospective, multicentre initiative with continuous data collection in consecutive patients with ACS, HF and A Fib to support continuous quality of care improvement through the evaluation of quality indicators (QIs) defined by the ESC. All patients included in the EuroHeart initiative, will enter a 12 month longitudinal follow-up with the collection of clinical events and clinical status data.
- Conditions
- ACS - Acute Coronary Syndrome
- Being tested
- Adherence to European Society of Cardiology (ESC) quality indicators
- Keywords
- Quality indicators, ACS, STEMI, NSTEMI, ESC, Guidelines
- Medical subject headings
- Acute Coronary Syndrome, ST Elevation Myocardial Infarction, Non-ST Elevated Myocardial Infarction
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Adherence to European Society of Cardiology (ESC) quality indicatorsOther
EuroHeart is an initiative of the European Society of Cardiology (ESC) supporting continuous quality-of-care improvement through individual patient data collection. The present registry component refers specifically to the Italian implementation of the EuroHeart programme, aimed at monitoring and improving adherence to ESC quality indicators within Italian clinical practice.
What is being measured
The primary outcome is the main question the study is designed to answer.
Adherence to ESC Quality indicators (STEMI patients reperfused)
Proportion of patients with STEMI reperfused among those eligible (onset of symptoms to diagnosis <12 hours)
Measured: From enrollment to 12 months follow-up
Adherence to ESC Quality indicators (STEMI patients reperfused <90 min)
Proportion of patients with STEMI who receive timely reperfusion with PCI (wire crossing) within 90 minutes from initial diagnostic ECG
Measured: From enrollment to 12 months follow-up
Adherence to ESC Quality indicators (coronary angiography in NSTEMI patients within 24 hours)
Rate of NSTEMI patients who receive invasive within 24 hours from their diagnosis
Measured: From enrollment to 12 months follow-up
Adherence to ESC Quality indicators (radial access)
Use of radial access in case of invasive strategy for patients with STEMI and NSTEMI
Measured: From enrollment to 12 months follow-up
Adherence to ESC Quality indicators (time to reperfusion in STEMI patients)
The time between the initial STEMI diagnosis and arterial access (absolute value) for primary PCI
Measured: From enrollment to 12 months follow-up
Adherence to ESC Quality indicators (pre-discharge LVEF evaluation in STEMI and NSTEMI patients)
The proportion of patients with STEMI and NSTEMI who have an assessment of their left ventricular ejection fraction (LVEF) before hospital discharge
Measured: From enrollment to 12 months follow-up
Adherence to ESC Quality indicators (in hospital LDL-c evaluation in STEMI and NSTEMI patients)
The proportion of patients with STEMI and NSTEMI who have their LDL cholesterol measured during hospitalization
Measured: From enrollment to 12 months follow-up
Adherence to ESC Quality indicators (DAPT prescription at discharge in STEMI and NSTEMI patients)
Proportion of patients with STEMI and NSTEMI discharged on dual antiplatelet therapy
Measured: From enrollment to 12 months follow-up
Adherence to ESC Quality indicators (LLA prescription at discharge in STEMI and NSTEMI patients)
Proportion of patients discharged from hospital on Lipid Lowering Agents (LLA)
Measured: From enrollment to 12 months follow-up
Adherence to ESC Quality indicators (ACEi/ARB/ARNI prescription at discharge in patients with LVEF ≤40%)
Proportion of patients with LVEF ≤40% who are discharged from hospital on angiotensin converting enzymes inhibitors (ACEi) or angiotensin receptor blockers (ARBs) or angiotensin receptor-neprilysin inhibitor (ARNI)
Measured: From enrollment to 12 months follow-up
Adherence to ESC Quality indicators (Beta blockers prescription at discharge in patients with LVEF ≤40%)
Proportion of patients with LVEF ≤40% who are discharged from hospital on beta blockers.
Measured: From enrollment to 12 months follow-up
Secondary outcomes (1)
Cardiovascular and non-cardiovascular events during follow-up
Proportion of patients with clinical events at 12 months
Measured: 12 months follow-up
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 Dec 2025
- Study start15 Sep 2024
- Primary completion15 Sep 2027 (estimated)
- Study completion30 Dec 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (6)Papers the sponsor has linked to this study.
- Other trials for ACS - Acute Coronary SyndromeStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 5,000 participants (estimated)
- Target duration
- 12 Months
Sponsor and investigators
- Lead sponsor
- Heart Care Foundation
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07283809
- Sponsor's protocol ID
- K27
- Acronym
- EuroHeart ITA
- Status last verified
- Jan 2026
- First submitted
- 2 Dec 2025
- Last updated
- 12 Jan 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Schiele F, Aktaa S, Rossello X, Ahrens I, Claeys MJ, Collet JP, Fox KAA, Gale CP, Huber K, Iakobishvili Z, Keys A, Lambrinou E, Leonardi S, Lettino M, Masoudi FA, Price S, Quinn T, Swahn E, Thiele H, Timmis A, Tubaro M, Vrints CJM, Walker D, Bueno H; ESC Scientific Document Group; Halvorsen S, Jernberg T, Jortveit J, Blondal M, Ibanez B, Hassager C. 2020 Update of the quality indicators for acute myocardial infarction: a position paper of the Association for Acute Cardiovascular Care: the study group for quality indicators from the ACVC and the NSTE-ACS guideline group. Eur Heart J Acute Cardiovasc Care. 2021 Apr 8;10(2):224-233. doi: 10.1093/ehjacc/zuaa037.
PubMed 33550362Batra G, Aktaa S, Camm AJ, Costa F, Di Biase L, Duncker D, Fauchier L, Fragakis N, Frost L, Hijazi Z, Juhlin T, Merino JL, Mont L, Nielsen JC, Oldgren J, Polewczyk A, Potpara T, Sacher F, Sommer P, Tilz R, Maggioni AP, Wallentin L, Casadei B, Gale CP. Data standards for atrial fibrillation/flutter and catheter ablation: the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart). Eur Heart J Qual Care Clin Outcomes. 2023 Sep 12;9(6):609-620. doi: 10.1093/ehjqcco/qcac068.
PubMed 36243903Aktaa S, Batra G, Cleland JGF, Coats A, Lund LH, McDonagh T, Rosano G, Seferovic P, Vasko P, Wallentin L, Maggioni AP, Casadei B, Gale CP; Heart Failure Association of the European Society of Cardiology. Data standards for heart failure: the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart). Eur Heart J. 2022 Jun 14;43(23):2185-2195. doi: 10.1093/eurheartj/ehac151.
PubMed 35443059Association of Cardiovascular Nursing and Allied Professions (ACNAP); Association for Acute CardioVascular Care (ACVC); European Association of Percutaneous Cardiovascular Interventions (EAPCI); EURObservational Research Programme (EORP); ESC Patient Forum; ESC Working Group on Thrombosis and ESC Committee for Young Cardiovascular Professionals; Batra G, Aktaa S, Wallentin L, Maggioni AP, Ludman P, Erlinge D, Casadei B, Gale CP. Data standards for acute coronary syndrome and percutaneous coronary intervention: the European Unified Registries for Heart Care Evaluation and Randomised Trials (EuroHeart). Eur Heart J. 2022 Jun 21;43(24):2269-2285. doi: 10.1093/eurheartj/ehac133.
PubMed 35380662Aktaa S, Batra G, Wallentin L, Baigent C, Erlinge D, James S, Ludman P, Maggioni AP, Price S, Weston C, Casadei B, Gale CP. European Society of Cardiology methodology for the development of quality indicators for the quantification of cardiovascular care and outcomes. Eur Heart J Qual Care Clin Outcomes. 2022 Jan 5;8(1):4-13. doi: 10.1093/ehjqcco/qcaa069.
PubMed 32845314Wallentin L, Gale CP, Maggioni A, Bardinet I, Casadei B. EuroHeart: European Unified Registries On Heart Care Evaluation and Randomized Trials. Eur Heart J. 2019 Sep 1;40(33):2745-2749. doi: 10.1093/eurheartj/ehz599. No abstract available.
PubMed 31505603
Study at a glance
From the registry record, last updated by the sponsor on 12 Jan 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- European Unified Registries for Heart Care Evaluation and Randomised Trials
- ClinicalTrials.gov ID
- NCT07283809
- Acronym / sponsor ID
- EuroHeart ITA / K27
- Conditions
- ACS - Acute Coronary Syndrome
- Keywords
- Quality indicators, ACS, STEMI, NSTEMI, ESC, Guidelines
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 5,000 participants (estimated)
- Lead sponsor
- Heart Care FoundationUniversity, hospital or other
- Study start
- 15 Sep 2024 (actual)
- Primary completion
- 15 Sep 2027 (estimated)
- Study completion
- 30 Dec 2027 (estimated)
- First posted
- 16 Dec 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Major advances in cardiovascular medicine have been driven by innovations in basic research in biological and technical sciences. Despite the clear evidence regarding the treatments that have been demonstrated to be useful to improve patients' outcomes, their transferability to everyday clinical practice seems to be at least suboptimal. The European Society of Cardiology (ESC), therefore, planned to support a program, denominated EuroHeart, for continuous data collection of standardized and/or harmonized variables in common cardiovascular diseases, such as ACS, HF and A Fib. EuroHeart is an observational, prospective, multicentre initiative with continuous data collection in consecutive patients with ACS, HF and A Fib to support continuous quality of care improvement through the evaluation of quality indicators (QIs) defined by the ESC. All patients included in the EuroHeart initiative, will enter a 12 month longitudinal follow-up with the collection of clinical events and clinical status data.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Target follow-up
- 12 Months
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- patients with ACS
Key inclusion criteria (7 listed)
- Patients ≥18 years of age.
- Males and females at birth.
- At least one of the following clinical conditions:
- Hospitalization for Acute Coronary Syndrome (ACS)
- Heart failure (HF, outpatients, and/or inpatients)
Key exclusion criteria (1 listed)
- patients who do not sign the consent to participate in the project and/or Privacy
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Adherence to European Society of Cardiology (ESC) quality indicatorsEuroHeart is an initiative of the European Society of Cardiology (ESC) supporting continuous quality-of-care improvement through individual patient data collection. The present registry component refers specifically to the Italian implementation of the EuroHeart programme, aimed at monitoring and improving adherence to ESC quality indicators within Italian clinical practice. | Other | – |
Primary outcome
Adherence to ESC Quality indicators (STEMI patients reperfused)
Time frame: From enrollment to 12 months follow-up
Proportion of patients with STEMI reperfused among those eligible (onset of symptoms to diagnosis <12 hours)
Adherence to ESC Quality indicators (STEMI patients reperfused <90 min)
Time frame: From enrollment to 12 months follow-up
Proportion of patients with STEMI who receive timely reperfusion with PCI (wire crossing) within 90 minutes from initial diagnostic ECG
Adherence to ESC Quality indicators (coronary angiography in NSTEMI patients within 24 hours)
Time frame: From enrollment to 12 months follow-up
Rate of NSTEMI patients who receive invasive within 24 hours from their diagnosis
Adherence to ESC Quality indicators (radial access)
Time frame: From enrollment to 12 months follow-up
Use of radial access in case of invasive strategy for patients with STEMI and NSTEMI
Adherence to ESC Quality indicators (time to reperfusion in STEMI patients)
Time frame: From enrollment to 12 months follow-up
The time between the initial STEMI diagnosis and arterial access (absolute value) for primary PCI
Adherence to ESC Quality indicators (pre-discharge LVEF evaluation in STEMI and NSTEMI patients)
Time frame: From enrollment to 12 months follow-up
The proportion of patients with STEMI and NSTEMI who have an assessment of their left ventricular ejection fraction (LVEF) before hospital discharge
Adherence to ESC Quality indicators (in hospital LDL-c evaluation in STEMI and NSTEMI patients)
Time frame: From enrollment to 12 months follow-up
The proportion of patients with STEMI and NSTEMI who have their LDL cholesterol measured during hospitalization
Adherence to ESC Quality indicators (DAPT prescription at discharge in STEMI and NSTEMI patients)
Time frame: From enrollment to 12 months follow-up
Proportion of patients with STEMI and NSTEMI discharged on dual antiplatelet therapy
Adherence to ESC Quality indicators (LLA prescription at discharge in STEMI and NSTEMI patients)
Time frame: From enrollment to 12 months follow-up
Proportion of patients discharged from hospital on Lipid Lowering Agents (LLA)
Adherence to ESC Quality indicators (ACEi/ARB/ARNI prescription at discharge in patients with LVEF ≤40%)
Time frame: From enrollment to 12 months follow-up
Proportion of patients with LVEF ≤40% who are discharged from hospital on angiotensin converting enzymes inhibitors (ACEi) or angiotensin receptor blockers (ARBs) or angiotensin receptor-neprilysin inhibitor (ARNI)
Adherence to ESC Quality indicators (Beta blockers prescription at discharge in patients with LVEF ≤40%)
Time frame: From enrollment to 12 months follow-up
Proportion of patients with LVEF ≤40% who are discharged from hospital on beta blockers.
1 secondary outcome
Cardiovascular and non-cardiovascular events during follow-up
Time frame: 12 months follow-up
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 12 Jan 2026.
- Background: PubMed 33550362Schiele F, Aktaa S, Rossello X, Ahrens I, Claeys MJ, Collet JP, Fox KAA, Gale CP, Huber K, Iakobishvili Z, Keys A, Lambrinou E, Leonardi S, Lettino M, Masoudi FA, Price S, Quinn T, Swahn E, Thiele H, Timmis A, Tubaro M, Vrints CJM, Walker D, Bueno H; ESC Scientific Document Group; Halvorsen S, Jernberg T, Jortveit J, Blondal M, Ibanez B, Hassager C. 2020 Update of the quality indicators for acute myocardial infarction: a position paper of the Association for Acute Cardiovascular Care: the study group for quality indicators from the ACVC and the NSTE-ACS guideline group. Eur Heart J Acute Cardiovasc Care. 2021 Apr 8;10(2):224-233. doi: 10.1093/ehjacc/zuaa037.
- Background: PubMed 36243903Batra G, Aktaa S, Camm AJ, Costa F, Di Biase L, Duncker D, Fauchier L, Fragakis N, Frost L, Hijazi Z, Juhlin T, Merino JL, Mont L, Nielsen JC, Oldgren J, Polewczyk A, Potpara T, Sacher F, Sommer P, Tilz R, Maggioni AP, Wallentin L, Casadei B, Gale CP. Data standards for atrial fibrillation/flutter and catheter ablation: the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart). Eur Heart J Qual Care Clin Outcomes. 2023 Sep 12;9(6):609-620. doi: 10.1093/ehjqcco/qcac068.
- Background: PubMed 35443059Aktaa S, Batra G, Cleland JGF, Coats A, Lund LH, McDonagh T, Rosano G, Seferovic P, Vasko P, Wallentin L, Maggioni AP, Casadei B, Gale CP; Heart Failure Association of the European Society of Cardiology. Data standards for heart failure: the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart). Eur Heart J. 2022 Jun 14;43(23):2185-2195. doi: 10.1093/eurheartj/ehac151.
- Background: PubMed 35380662Association of Cardiovascular Nursing and Allied Professions (ACNAP); Association for Acute CardioVascular Care (ACVC); European Association of Percutaneous Cardiovascular Interventions (EAPCI); EURObservational Research Programme (EORP); ESC Patient Forum; ESC Working Group on Thrombosis and ESC Committee for Young Cardiovascular Professionals; Batra G, Aktaa S, Wallentin L, Maggioni AP, Ludman P, Erlinge D, Casadei B, Gale CP. Data standards for acute coronary syndrome and percutaneous coronary intervention: the European Unified Registries for Heart Care Evaluation and Randomised Trials (EuroHeart). Eur Heart J. 2022 Jun 21;43(24):2269-2285. doi: 10.1093/eurheartj/ehac133.
- Background: PubMed 32845314Aktaa S, Batra G, Wallentin L, Baigent C, Erlinge D, James S, Ludman P, Maggioni AP, Price S, Weston C, Casadei B, Gale CP. European Society of Cardiology methodology for the development of quality indicators for the quantification of cardiovascular care and outcomes. Eur Heart J Qual Care Clin Outcomes. 2022 Jan 5;8(1):4-13. doi: 10.1093/ehjqcco/qcaa069.
- Background: PubMed 31505603Wallentin L, Gale CP, Maggioni A, Bardinet I, Casadei B. EuroHeart: European Unified Registries On Heart Care Evaluation and Randomized Trials. Eur Heart J. 2019 Sep 1;40(33):2745-2749. doi: 10.1093/eurheartj/ehz599. No abstract available.
- Individual participant dataSharing planned: No
Related trials for ACS - Acute Coronary Syndrome
RecruitingPhase 4
Early Single Antiplatelet Therapy After IVUS-Guided PCI in Acute Coronary Syndrome
Acute Coronary Syndromes, STEMI
Recruiting
AI-Assisted Interpretation of Cardiac CT in the Emergency Department
Chest Pain, Acute Coronary Syndrome
Enrolling by invitation
Optical Coherence Tomography in Acute Vessel Evaluation
Ischemic Heart Disease, Ischemic Coronary Artery Disease
RecruitingPhase 4
CCTA Evaluation of SGLT2i-related Pericoronary Fat Changes Patients With Stage 4 CKM Syndrome
ACS (Acute Coronary Syndrome), SGLT2 Inhibitors
Not yet recruitingPhase 4
Comparative Assessment of Inclisiran on Top of Standard of Care Versus Standard of Care Alone for LDL-C Evaluation in Acute Coronary Syndrome Patients in Saudi Arabia
Acute Coronary Syndrome
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
57 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of ACS - Acute Coronary Syndrome, run by Heart Care Foundation at 57 sites in Italy.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 12 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 57 sites in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Furio Colivicchi, MD (055/51013741, euroheart.italia@heartcarefoundation.itON.IT), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Adherence to ESC Quality indicators (STEMI patients reperfused) (time frame: From enrollment to 12 months follow-up). The study lists 11 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07283809, which also lists 6 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Jan 2026.